Macula Densa SGLT1-NOS1-Tubuloglomerular Feedback Pathway, a New Mechanism for Glomerular Hyperfiltration during Hyperglycemia

J Am Soc Nephrol. 2019 Apr;30(4):578-593. doi: 10.1681/ASN.2018080844. Epub 2019 Mar 13.

Abstract

Background: Glomerular hyperfiltration is common in early diabetes and is considered a risk factor for later diabetic nephropathy. We propose that sodium-glucose cotransporter 1 (SGLT1) senses increases in luminal glucose at the macula densa, enhancing generation of neuronal nitric oxide synthase 1 (NOS1)-dependent nitric oxide (NO) in the macula densa and blunting the tubuloglomerular feedback (TGF) response, thereby promoting the rise in GFR.

Methods: We used microperfusion, micropuncture, and renal clearance of FITC-inulin to examine the effects of tubular glucose on NO generation at the macula densa, TGF, and GFR in wild-type and macula densa-specific NOS1 knockout mice.

Results: Acute intravenous injection of glucose induced hyperglycemia and glucosuria with increased GFR in mice. We found that tubular glucose blunts the TGF response in vivo and in vitro and stimulates NO generation at the macula densa. We also showed that SGLT1 is expressed at the macula densa; in the presence of tubular glucose, SGLT1 inhibits TGF and NO generation, but this action is blocked when the SGLT1 inhibitor KGA-2727 is present. In addition, we demonstrated that glucose increases NOS1 expression and NOS1 phosphorylation at Ser1417 in mouse renal cortex and cultured human kidney tissue. In macula densa-specific NOS1 knockout mice, glucose had no effect on NO generation, TGF, and GFR.

Conclusions: We identified a novel mechanism of acute hyperglycemia-induced hyperfiltration wherein increases in luminal glucose at the macula densa upregulate the expression and activity of NOS1 via SGLT1, blunting the TGF response and promoting glomerular hyperfiltration.

Keywords: NOS1; SGLT1; glomerular hyperfiltration; hyperglycemia; tubuloglomerular feedback.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Feedback, Physiological
  • Glomerular Filtration Rate
  • Glucose / metabolism*
  • Glucosides / pharmacology
  • Humans
  • Hyperglycemia / physiopathology*
  • Inulin / metabolism
  • Kidney Glomerulus / metabolism
  • Kidney Glomerulus / physiopathology*
  • Kidney Tubules, Distal / metabolism*
  • Kidney Tubules, Distal / physiopathology
  • Male
  • Mice
  • Mice, Knockout
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase Type I / genetics
  • Nitric Oxide Synthase Type I / metabolism*
  • Phosphorylation
  • Pyrazoles / pharmacology
  • Signal Transduction
  • Sodium-Glucose Transporter 1 / antagonists & inhibitors
  • Sodium-Glucose Transporter 1 / metabolism*

Substances

  • 3-(3-(4-(3-(glucopyranosyloxy)-5-isopropyl-1H-pyrazol-4-ylmethyl)-3-methylphenoxy)propylamino)propionamide
  • Glucosides
  • Pyrazoles
  • Slc5a1 protein, mouse
  • Sodium-Glucose Transporter 1
  • Nitric Oxide
  • Inulin
  • NOS1 protein, human
  • Nitric Oxide Synthase Type I
  • Nos1 protein, mouse
  • Glucose